KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Intangibles: 2016-2024

Historic Change in Intangibles for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $14.7 million.

  • Amneal Pharmaceuticals' Change in Intangibles rose 105.94% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 61.37%. This contributed to the annual value of $14.7 million for FY2024, which is 34.56% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Change in Intangibles of $14.7 million as of FY2024, which was down 34.56% from $22.4 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Change in Intangibles registered a high of $41.8 million during FY2022, and its lowest value of $1.7 million during FY2021.
  • Over the past 3 years, Amneal Pharmaceuticals' median Change in Intangibles value was $22.4 million (recorded in 2023), while the average stood at $26.3 million.
  • In the last 5 years, Amneal Pharmaceuticals' Change in Intangibles tumbled by 91.34% in 2020 and then spiked by 2,358.82% in 2022.
  • Amneal Pharmaceuticals' Change in Intangibles (Yearly) stood at $4.3 million in 2020, then tumbled by 60.92% to $1.7 million in 2021, then skyrocketed by 2,358.82% to $41.8 million in 2022, then plummeted by 46.44% to $22.4 million in 2023, then crashed by 34.56% to $14.7 million in 2024.